# DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE
> **ANDA076536** · Abbreviated New Drug Application (Generic) · Sponsor: BARR LABS INC · Approved 2013-02-12
## Drug
- **FDA Application Number:** ANDA076536
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE
- **Generic name:** Amphetamine Aspartate
- **Active ingredients:** AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** BARR LABS INC
- **First approval:** 2013-02-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076536)
---
*AI Analytics · CC0 1.0*